Status:
COMPLETED
A Phase 1 Drug-drug Interaction Study in Healthy Volunteers
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Drug-drug Interaction Study
Eligibility:
All Genders
18-50 years
Phase:
PHASE1
Brief Summary
This is an open-label, single-sequence, drug-drug interaction study in healthy male and female subjects. There is no formal research hypothesis to be statistically tested. It is expected that coadmini...
Eligibility Criteria
Inclusion
- Healthy male and female nonsmoking subjects ages 18 to 50 years, inclusive, with a body mass index of 18.0 to 32.0 kg/m2, inclusive
- Women of childbearing potential must agree to follow instructions for methods of contraception for the duration of the study
Exclusion
- Any significant acute or chronic medical illness
- History of arrhythmias or palpitations associated with dizziness or fainting
- History of clinically relevant cardiac disease
- Other protocol defined exclusion criteria could apply
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT02227173
Start Date
September 1 2014
End Date
November 1 2014
Last Update
November 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Healthcare Discoveries, LLC d/b/a ICON Development Solutions
San Antonio, Texas, United States, 78209